Sort
82,697 grants matching “vaccine development”
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSES
$1,111,778Michael S. Diamond · Washington University · U01 · FY2025 · AI
LIVE, ATTENUATED, RECOMBINANT VACCINE - WEST NILE VIRUS
$1,111,767Acambis, Inc. · R01 · FY2001 · AI
Processing Of Viral Proteins For T Cell Recognition
$1,111,746Jack R Bennink · Niaid Extramural Activities · Z01 · FY2007 · AI
Preclinical evaluation of a potent Lassa fever immunotherapeutic antibody cocktail
$1,111,574Robert F Garry · Tulane University Of Louisiana · R01 · FY2019 · AI
Core 1 - Structural Biology Core
$1,111,515Priyamvada Acharya · Duke University · U54 · FY2023 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,111,301Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,110,860Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
IMMUNITY TO STDS IN THE HUMAN MALE GENITAL TRACT
$1,110,840Boston University Medical Campus · P01 · FY2004 · AI
Development of Small Molecule Therapeutics Against Smallpox and Other Poxviruses
$1,110,810Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2015 · AI
Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection
$1,110,806Karen Thompson · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2021 · AI
Fogarty AIDS International Training and Research Program (AITRP)
$1,110,701Chris Beyrer · Johns Hopkins University · D43 · FY2010 · TW
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$1,110,635James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Combinational Immunotherapies to Amplify Vaccine Induced Immunity
$1,110,621Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2008 · CA
Modeling human hepatotropic infections in complex tissue organoids
$1,110,614Charles M. Rice · Rockefeller University · R01 · FY2012 · DK
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,110,488Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse
$1,110,301Chang-Guo Zhan · University Of Kentucky · UH2 · FY2016 · DA
Evaluation of the Immunogenicity and Efficacy of HIV-1 SOSIP Envelope Protein Vaccine Delivered with or without Recombinant Viral Vector Vaccines
$1,110,234Ronald S. Veazey · Tulane University Of Louisiana · N01 · FY2023 · AI
Chicago Clinical Trials Unit
$1,110,190Chad J Achenbach · Northwestern University At Chicago · UM1 · FY2025 · AI
A Therapeutic DNA Epitope Vaccine for Alzheimer's Disease
$1,109,875Claire Frances Evans · Ichor Medical Systems, Inc. · U44 · FY2011 · NS
Molecular Basis of Francisella tularensis-Macrophage Interactions
$1,109,832Jean Celli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Microfabrication for Biomedical Research
$1,109,565Nicole Y Morgan · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2022 · EB
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,109,557Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,109,557Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Clinical Research in the NIMH Office of the Clinical Director
$1,109,429Maryland Pao · National Institute Of Mental Health · ZIA · FY2023 · MH
Vectors and Methods to Increase Immunogenicity during DNA Vaccination
$1,109,300Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI